Loading clinical trials...
Loading clinical trials...
Prospective, Randomized Controlled Trial to Investigate the Impact of AI on Shared Decision Making in Post-kidney Transplant Care
This study aims to analyze the effects of AI-based risk prediction for graft loss on the frequency of conversations about the treatment after graft loss, as well as the associated shared decision making process in post-kidney transplant care in a German kidney transplant center (KTC), as perceived by the patient, their support person and the clinician/physician. Second, it aims to explore changes in patient and support person recall at 12 and 24 months follow-up. Implementation barriers and enablers will also be assessed.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, Germany
Start Date
January 19, 2024
Primary Completion Date
September 1, 2025
Completion Date
September 1, 2026
Last Updated
January 20, 2025
76
ACTUAL participants
AI-based risk prediction for kidney graft loss
OTHER
Lead Sponsor
Charite University, Berlin, Germany
NCT05525507
NCT05788276
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions